PASG
Passage Bio, Inc. · Healthcare
Orbimed Advisors LLC bought $1.0M of Passage Bio, Inc.
10% owner
Bought$1,016,285
$1.94Price
525,000Shares
+8%Stake
What PASG did for a copier
- $1,000 copied at Fri, May 6 open, $43.20
- $1,051
- S&P 500, same days
- −8.4%
Measured over 30 trading days, to the Jun 21 close.
Orbimed Advisors LLC's record
34 other buys with 3 months of prices since 2016: on average −12.8% against the S&P 500, and 12 of 34 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, May 3. Filed Thu, May 5. Returns use the May 6 open and the Jun 21 close. Not investment advice.